Islam R, Bilal H, Wang X, Zhang L
BENEFITS: Speeds up tissue repair for accelerated healing Reduces inflammation, joint pain, and localized swelling Improves skin firmness, elasticity, and tone Stimulates collagen and elastin helping strengthen tissue and reverse signs of aging or injury Enhances flexibility by targeting connective tissue and reducing fibrosis
Excellent for post-peel and post-CO2 laser treatments

Compared with the structure of human GLP-1(7-37), the amino acid sequence of dulaglutide contains glycine at position 8, glutamic acid at position 22, and glycine at position 36.113 It was then fused to the constant region (Fc) of modified human immunoglobulin G4 (IgG4) via a -(Gly-Gly-Gly-Gly-Ser) 3-Ala- bridge and exhibits an average biological half-life of 90 h.105 Dulaglutide is the first large-molecule GLP-1RA, and the weekly dosing frequency of dulaglutide can greatly improve patient compliance.33,78,104,114 Semaglutide Semaglutide is a long-acting GLP-1RA agent used once weekly to improve glycemic control in patients with T2DM.115 Compared with the structure of human GLP-1(7-37), the amino acid sequence of semaglutide contains diaminoisobutyric acid at position 8, arginine at position 34, and acylated lysine at position 26.31 Semaglutide has a longer aliphatic chain and increased hydrophobicity, but its hydrophilicity is greatly enhanced by PEG modification of the short chain

This article explores the exciting potential of GLP-1 Drugs in tackling a range of obesity-related illnesses, promising a future where these drugs become cornerstones of a healthier world